Equity Transactions (Details Narrative) - USD ($)		3 Months Ended	6 Months Ended
	Feb. 02, 2021	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022	Jun. 30, 2022
Common stock issued during period for acquisition value				$ 35,000
Shares of common stock for consulting service, value				175,000
Common shares value			$ 17,960		$ 16,713	$ 16,713
Common stock issued during period for acquisition value		$ 33,740		$ 33,740
Common stock issued during period for acquisition				4,000,000
Common Stock Shares [Member]
Shares of common stock for consulting service, value				$ 4,000,000
Common stock issued during period for acquisition value			$ 6,000,000	$ 6,000,000
Common stock issued during period for acquisition			1,247,403	1,247,403
Shares of common stock for consulting service, shares				666,667
Convertible Preferred Stock [Member]
Sale of preferred stock shares	500,000
Preferred stock convertible into shares of common stock ratio	preferred stock is convertible into the Company’s common stock at a ratio of 1.8 shares of preferred stock for a single share
FinderFee [Member]
Common shares value					$ 33,740
Common stock issued during period for acquisition value			$ 33,740	$ 33,740
Common stock issued during period for acquisition			7,000	7,000
VitaMedica [Member]
Common stock issued during period for acquisition value				$ 100,000
Common stock issued during period for acquisition				482,000
Infusionz [Member] | Common Stocks [Member]
Common stock issued during period for acquisition value				$ 1,764,876
Common stock issued during period for acquisition				306,945